cocodentax ltd
cocodentax ltd Company Information
Group Structure
View All
Industry
Manufacture of basic pharmaceutical products
Registered Address
20-22 wenlock road, london, N1 7GU
Website
-cocodentax ltd Estimated Valuation
Pomanda estimates the enterprise value of COCODENTAX LTD at £71.8k based on a Turnover of £67.5k and 1.06x industry multiple (adjusted for size and gross margin).
cocodentax ltd Estimated Valuation
Pomanda estimates the enterprise value of COCODENTAX LTD at £2.6k based on an EBITDA of £568 and a 4.56x industry multiple (adjusted for size and gross margin).
cocodentax ltd Estimated Valuation
Pomanda estimates the enterprise value of COCODENTAX LTD at £9.9k based on Net Assets of £5.7k and 1.75x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Cocodentax Ltd Overview
Cocodentax Ltd is a live company located in london, N1 7GU with a Companies House number of 11305905. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in April 2018, it's largest shareholder is grzegorz guzek with a 100% stake. Cocodentax Ltd is a young, micro sized company, Pomanda has estimated its turnover at £67.5k with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Cocodentax Ltd Health Check
Pomanda's financial health check has awarded Cocodentax Ltd a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs
2 Strong
1 Regular
7 Weak
Size
annual sales of £67.5k, make it smaller than the average company (£33.5m)
- Cocodentax Ltd
£33.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 174%, show it is growing at a faster rate (4.9%)
- Cocodentax Ltd
4.9% - Industry AVG
Production
with a gross margin of 20.2%, this company has a higher cost of product (38%)
- Cocodentax Ltd
38% - Industry AVG
Profitability
an operating margin of 0.8% make it less profitable than the average company (6.5%)
- Cocodentax Ltd
6.5% - Industry AVG
Employees
with 1 employees, this is below the industry average (112)
- Cocodentax Ltd
112 - Industry AVG
Pay Structure
on an average salary of £61.9k, the company has an equivalent pay structure (£61.9k)
- Cocodentax Ltd
£61.9k - Industry AVG
Efficiency
resulting in sales per employee of £67.5k, this is less efficient (£401.7k)
- Cocodentax Ltd
£401.7k - Industry AVG
Debtor Days
it gets paid by customers after 90 days, this is later than average (57 days)
- Cocodentax Ltd
57 days - Industry AVG
Creditor Days
its suppliers are paid after 75 days, this is slower than average (36 days)
- Cocodentax Ltd
36 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Cocodentax Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Cocodentax Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 66.3%, this is a higher level of debt than the average (46.2%)
66.3% - Cocodentax Ltd
46.2% - Industry AVG
COCODENTAX LTD financials
Cocodentax Ltd's latest turnover from April 2023 is estimated at £67.5 thousand and the company has net assets of £5.7 thousand. According to their latest financial statements, we estimate that Cocodentax Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | |
|---|---|---|---|---|---|
| Turnover | |||||
| Other Income Or Grants | |||||
| Cost Of Sales | |||||
| Gross Profit | |||||
| Admin Expenses | |||||
| Operating Profit | |||||
| Interest Payable | |||||
| Interest Receivable | |||||
| Pre-Tax Profit | |||||
| Tax | |||||
| Profit After Tax | |||||
| Dividends Paid | |||||
| Retained Profit | |||||
| Employee Costs | |||||
| Number Of Employees | |||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | |
|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 16,776 | 19,767 | 25,476 | 977 | 113 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 |
| total current assets | 16,776 | 19,767 | 25,476 | 977 | 113 |
| total assets | 16,776 | 19,767 | 25,476 | 977 | 113 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 11,125 | 14,542 | 20,897 | 179 | 35 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 11,125 | 14,542 | 20,897 | 179 | 35 |
| loans | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 11,125 | 14,542 | 20,897 | 179 | 35 |
| net assets | 5,651 | 5,225 | 4,579 | 798 | 78 |
| total shareholders funds | 5,651 | 5,225 | 4,579 | 798 | 78 |
| Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Operating Profit | |||||
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 |
| Tax | |||||
| Stock | 0 | 0 | 0 | 0 | 0 |
| Debtors | -2,991 | -5,709 | 24,499 | 864 | 113 |
| Creditors | -3,417 | -6,355 | 20,718 | 144 | 35 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||
| Investing Activities | |||||
| capital expenditure | |||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||
| Financing Activities | |||||
| Bank loans | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||
| interest | |||||
| cash flow from financing | |||||
| cash and cash equivalents | |||||
| cash | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 |
cocodentax ltd Credit Report and Business Information
Cocodentax Ltd Competitor Analysis
Perform a competitor analysis for cocodentax ltd by selecting its closest rivals, whether from the MANUFACTURING sector, other micro companies, companies in N 1 area or any other competitors across 12 key performance metrics.
cocodentax ltd Ownership
COCODENTAX LTD group structure
Cocodentax Ltd has no subsidiary companies.
Ultimate parent company
COCODENTAX LTD
11305905
cocodentax ltd directors
Cocodentax Ltd currently has 1 director, Mr Grzegorz Guzek serving since Apr 2018.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Grzegorz Guzek | England | 47 years | Apr 2018 | - | Director |
P&L
April 2023turnover
67.5k
-15%
operating profit
568
0%
gross margin
20.2%
-7.79%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
April 2023net assets
5.7k
+0.08%
total assets
16.8k
-0.15%
cash
0
0%
net assets
Total assets minus all liabilities
cocodentax ltd company details
company number
11305905
Type
Private limited with Share Capital
industry
21100 - Manufacture of basic pharmaceutical products
incorporation date
April 2018
age
7
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
April 2023
previous names
N/A
accountant
-
auditor
-
address
20-22 wenlock road, london, N1 7GU
Bank
-
Legal Advisor
-
cocodentax ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to cocodentax ltd.
cocodentax ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for COCODENTAX LTD. This can take several minutes, an email will notify you when this has completed.
cocodentax ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
